Patents by Inventor Siling Zhao

Siling Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20240425525
    Abstract: The present disclosure provides compounds and pharmaceutically acceptable salts thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of oncogenic proteins.
    Type: Application
    Filed: July 29, 2024
    Publication date: December 26, 2024
    Inventors: Pingda Ren, Liansheng Li, Baogen Wu, Xiaoming Li, Zhiyong Chen, Siling Zhao, Yi Liu, Xiuwen Zhu
  • HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20240425522
    Abstract: The present disclosure provides compounds and pharmaceutically acceptable salts thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of oncogenic proteins.
    Type: Application
    Filed: May 17, 2024
    Publication date: December 26, 2024
    Inventors: Pingda Ren, Liansheng Li, Baogen Wu, Xiaoming Li, Zhiyong Chen, Siling Zhao, Yi Liu, Xiuwen Zhu
  • HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20240390389
    Abstract: The present disclosure provides compounds and pharmaceutically acceptable salts thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of certain oncogenic proteins.
    Type: Application
    Filed: April 12, 2024
    Publication date: November 28, 2024
    Inventors: Baogen Wu, Liansheng Li, Pingda Ren, Yi Liu, Siling Zhao, Xiaoming Li, Zhiyong Chen, Zhimin Zhu
  • MACROCYCLIC HETEROCYCLES AND USES THEREOF
    Publication number: 20240270736
    Abstract: The present disclosure provides compounds and pharmaceutically acceptable salts thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of oncogenic proteins.
    Type: Application
    Filed: November 28, 2023
    Publication date: August 15, 2024
    Inventors: Baogen Wu, Liansheng Li, Pingda Ren, Zhiyong Chen, Siling Zhao, Xiuwen Zhu
  • Heterocyclic compounds and uses thereof
    Patent number: 12059425
    Abstract: The present disclosure provides compounds and pharmaceutically acceptable salts thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of certain oncogenic proteins.
    Type: Grant
    Filed: February 12, 2024
    Date of Patent: August 13, 2024
    Assignee: Kumquat Biosciences Inc.
    Inventors: Baogen Wu, Liansheng Li, Pingda Ren, Yi Liu, Siling Zhao, Xiaoming Li, Zhiyong Chen, Zhimin Zhu
  • HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20240226113
    Abstract: The present disclosure provides compounds and pharmaceutically acceptable salts thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of certain oncogenic proteins.
    Type: Application
    Filed: February 12, 2024
    Publication date: July 11, 2024
    Inventors: Baogen Wu, Liansheng Li, Pingda Ren, Yi Liu, Siling Zhao, Xiaoming Li, Zhiyong Chen, Zhimin Zhu
  • HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20240109918
    Abstract: The present disclosure provides compounds and pharmaceutically acceptable salts thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of oncogenic proteins.
    Type: Application
    Filed: May 3, 2023
    Publication date: April 4, 2024
    Inventors: Xiaoming Li, Yuan Liu, Pingda Ren, Liansheng Li, Zhiyong Chen, Baogen Wu, Siling Zhao